AIxCrypto Holdings (NASDAQ:AIXC) detailed its year-end financial position on Wednesday, formalizing the financial impact of its wholesale strategic pivot from clinical-stage biotechnology to artificial intelligence and blockchain infrastructure.
The full-year 2025 results underscore a drastically reshaped balance sheet following the closure of a $41 million private investment in public equity (PIPE) transaction.
This capital injection has positioned the newly rebranded entity with approximately $31 million in total assets against a lean liability profile of roughly $3 million.
The company's liquidity position is anchored by approximately $19 million in cash reserves, operating alongside a growing digital asset treasury valued at $10 million.
Consequently, total shareholder equity stands at roughly $28 million.
The financial disclosures map the aftermath of the company's official corporate rebrand and Nasdaq debut under its new ticker, which occurred on November 20, 2025.
By abandoning its legacy biotech pipeline, management has shifted its entire operational focus toward scaling its digital network.
Operational data released alongside the financials indicates rapid market penetration for the new platform.
As of March 16, 2026, the company reported its infrastructure currently supports 5,835,615 registered digital wallets.
Furthermore, the network is seeing high engagement, logging 1,392,427 daily active participants.